Newsletter Subject

The most exciting treatment innovations we expect in 2024

From

time.com

Email Address

TIME@newsletters.time.com

Sent On

Thu, Jan 4, 2024 09:53 PM

Email Preheader Text

Plus more health news | Email not displaying correctly? By Alice Park Senior Health Correspondent A

Plus more health news | Email not displaying correctly? [View it in your browser.]( [Health Matters]( [Here are the new drugs and treatments we could see in 2024]( By Alice Park Senior Health Correspondent A new year brings new opportunities, and that includes for innovative medical treatments. The U.S. Food and Drug Administration (FDA) will be busy reviewing a number of novel therapies this year. First up could be a treatment for Alzheimer’s disease from Eli Lilly that promises to be the most effective yet in reducing the buildup of disease-contributing amyloid plaques in the brain. If approved, it would give patients another powerful option for managing the memory disorder. The FDA will also consider expanding approval of the first gene editing treatment, using CRISPR, which it approved to treat sickle cell anemia in 2023. This year, the agency will decide whether people with another genetic blood disorder, beta thalassemia, could also benefit from the technology, which gives people more blood cells that can carry oxygen. In the field of mental health, people with schizophrenia could see the first new treatment in decades if the FDA greenlights a medication that targets a different brain chemical than existing ones to reduce the condition’s peaks and valleys of positive and negative thoughts and mood. Health experts and patient advocates say that ensuring affordable access will be just as important as securing approval for these exciting new treatments. Many of the therapies are designed as one-time medications, rather than chronic interventions, and come with high upfront costs. That’s led some insurers to not commit to reimbursing for them. But many experts believe these novel medicines could end up saving the health care system money—and lives—in the long run. [READ THE REST]( Share This Story WHAT ELSE TO READ [Wearing Hearing Aids May Help You Live Longer]( By Haley Weiss Social isolation, depression, anxiety, and dementia have all been linked to hearing loss. [Read More »]( [This Is the Best Time of Day to Work Out, According to Science]( By Jamie Ducharme If you want to optimize your workouts to get the widest range of benefits, you might want to try exercising in the morning. (Originally published in 2019.) [Read More »]( [6 Surprising Things You Think Are Making You Happy—But Are Doing the Opposite]( By Angela Haupt Chasing career success, dodging negative emotions, and living in a city all make the list. [Read More »]( [Why You’re Grinding Your Teeth—And How to Stop]( By Haley Weiss Bruxism, or teeth-grinding, has increased during the pandemic because of stress, anxiety, and more. [Read More »]( [6 Ways to Tap Into Nostalgia—and Why You Should]( By Angela Haupt How to tap into nostalgia to feel more connected to other people, find meaning in life, and build self-esteem. [Read More »]( AN EXPERT VOICE "[An easy way to know if you're getting enough nutrients is to] look at your plate. Are there three natural colors on it? Ideally there should be at least three or four." —Drew Ramsey, nutritional psychiatrist at Columbia University If you were forwarded this and want to sign up to receive it daily, [click here](. Today's newsletter was written by Alice Park and Jamie Ducharme, and edited by Angela Haupt. [Want more from TIME? Sign up for our other newsletters.]( [Subscribe to TIME]( TIME may receive compensation for some links to products and services in this email. Offers may be subject to change without notice. Connect with TIME via [Facebook]( | [Twitter]( | [Newsletters]( [UNSUBSCRIBE]( [PRIVACY POLICY]( [YOUR CALIFORNIA PRIVACY RIGHTS]( TIME Customer Service, P.O. Box 37508, Boone, IA 50037-0508 Questions? Contact health@time.com Copyright © 2024 TIME USA, LLC. All rights reserved.

Marketing emails from time.com

View More
Sent On

31/10/2024

Sent On

29/10/2024

Sent On

28/10/2024

Sent On

24/10/2024

Sent On

15/10/2024

Sent On

03/10/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.